Search
7th European CAR T-cell Meeting
The European Hematology Association (EHA) and the EBMT are excited to announce the 7th edition of the jointly organized European CAR T-cell Meeting.
Read morePublications
HemaSphere - the official open access journal of EHAHemaSphere is the official open access, peer-reviewed journal of EHA, supporting hematology researchers by offering a fast and constructive review process and low publication fees.
Read moreCRYSTAL-Immune pump-priming project
Project team
Christina Halsey
Positions: Professor of Paediatric Haemato-Oncology & Head of School, School of Cancer Sciences, University of Glasgow, and Honorary Consultant Paediatric Haematologist, Royal Hospital for Children, Glasgow.
SWG Grant-funded projects, 2025
In November and December 2024, SWGs were invited to develop project ideas and apply for a 2025 SWG Grant. For the 2025 call, EHA offered five grants, each worth €30,000.
Read moreSpecialized Working Group Grants
EHA provides financial support to small research projects initiated by our specialized working groups (SWGs).
Read moreSWG Grant-funded projects, 2024
In November and December of 2023, SWGs were invited to develop project ideas and apply for a 2024 SWG Grant. ApplicationsWe received 11 different applications from 9 SWGs. This was two more applications than we received in 2022.
Read moreThe European Health Data Space Regulation is a reality
The European Health Data Space (EHDS) Regulation has made it to the EU’s Official Journal, almost three years after the initial proposal was published.
Read moreEHA Research Mobility Grants
The call for applications is currently closed
EHA strives to develop the career of young scientists by supporting mobility and facilitating a visit to a research group in another institute.
Grants & abstract awards
EHA Travel GrantsThe call for travel grant applications closed on March 1, 2025 (23:59 CET). The grants will only be available for investigators with accepted abstracts, submitted during the regular abstract submission.
Read moreSelected EMA news
March 2025New medicines recommended for approval
Lynozyfic (linvoseltamab)
Treatment of refractory multiple myeloma (a cancer of the bone marrow)
New information on approved medicines
Calquence (acalabrutinib) - new indication
Treatment of blood cancer
Columvi (glofitamab) - new indication
Treatment of blood cancer
Darzalex (daratumumab) - change of indication
Treatment…